Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-03-28 3:30 pm Unchanged | 13G | NEUROBO PHARMACEUTICALS INC CO NRBO | Strategic Risk LLC. | 1,202,833 6.3% | 0 (Unchanged) | View |
| 2023-02-14 12:35 pm Sale | 13G | NEUROBO PHARMACEUTICALS INC CO NRBO | Altium Capital Management LP | 0 0% | -333,333 (Position Closed) | View |
| 2022-12-29 7:43 pm Purchase | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | DONG-A ST CO. LTD | 12,429,353 65.5% | 12,333,333 (+12844.55%) | View |
| 2022-11-17 5:08 pm Purchase | 13G | NEUROBO PHARMACEUTICALS INC CO NRBO | Altium Capital Management LP | 333,333 7.7% | 333,333 (New Position) | View |
| 2022-11-10 4:14 pm Purchase | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | DONG-A ST CO. LTD | 96,020 2.4% | 96,020 (New Position) | View |
| 2022-09-23 4:20 pm Sale | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | JK BioPharma Solutions Inc | 0 0% | -2,618,012 (Position Closed) | View |
| 2022-09-16 4:46 pm Sale | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | DONG-A ST CO. LTD | 96,020 10.7% | -2,784,592 (-96.67%) | View |
| 2022-08-05 4:25 pm Sale | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | E&Investment Inc. | 6,113,798 22.9% | -1,207,991 (-16.50%) | View |
| 2021-11-10 2:17 pm Unchanged | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | JK BioPharma Solutions Inc | 2,618,012 9.8% | 0 (Unchanged) | View |
| 2021-09-01 4:20 pm Unchanged | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | DONG-A ST CO. LTD | 2,880,612 12.9% | 0 (Unchanged) | View |
| 2021-08-30 10:27 am Unchanged | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | E&Investment Inc. | 7,321,789 32.9% | 0 (Unchanged) | View |
| 2021-08-27 9:11 pm Unchanged | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | DONG-A ST CO. LTD | 2,880,612 12.9% | 0 (Unchanged) | View |
| 2021-03-15 06:05 am Unchanged | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | E&Investment Inc. | 7,321,789 33% | 0 (Unchanged) | View |
| 2021-03-11 06:08 am Unchanged | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | DONG-A ST CO. LTD | 2,880,612 13% | 0 (Unchanged) | View |
| 2020-02-13 1:45 pm Purchase | 13G | NEUROBO PHARMACEUTICALS INC CO NRBO | Freeman Roy Lester | 1,456,160 9.3% | 1,456,160 (New Position) | View |
| 2020-01-16 4:41 pm Unchanged | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | NEUROBO THERAPEUTICS INC. | 0 0% | 0 (Unchanged) | View |
| 2020-01-10 09:51 am Purchase | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | JK BioPharma Solutions Inc | 2,618,012 16.7% | 2,618,012 (New Position) | View |
| 2020-01-10 09:51 am Purchase | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | E&Investment Inc. | 7,321,789 46.8% | 7,321,789 (New Position) | View |
| 2020-01-10 08:28 am Purchase | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | Bisgaier Charles PhD | 58,012 0.4% | 58,012 (New Position) | View |
| 2020-01-09 4:52 pm Purchase | 13G | NEUROBO PHARMACEUTICALS INC CO NRBO | DONG-A ST CO. LTD | 2,880,612 18.5% | 2,880,612 (New Position) | View |